Rayaldee Capsule, Extended Release
Product Images NDC 70301-1002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rayaldee (NDC 70301-1002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opko Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Calcifediol Chemical Structure (Image 01)

FDA Label Image

Figure 1 (Image 02)

FDA Label Image

Principal Display Panil (Image 03)

Principal Display Panil (Image 03)
Rayaldee® (calcifediol) is an extended-release capsule used for treating patients with chronic kidney disease. Each capsule contains 30mcg of calcifediol. It can only be obtained through a prescription. The manufacturer is OPKO Pharmaceuticals, LLC. Further information on the drug can be found in the package insert provided along with the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.